U.S. brands face EU AI Act exposure through European users

The EU AI Act can apply to U.S. companies that place AI systems on the EU market, put them into service in the EU, or use outputs that affect European users. The scope covers providers regardless of where they are based, as well as deployers, importers, and distributors. Exposure can arise through SaaS products accessible to European users, AI hiring tools evaluating candidates in Europe, personalization aimed at EU consumers, customer support systems interacting with EU residents, and advertising or partner infrastructure.

Brand uses are framed across risk tiers ranging from prohibited systems to high-risk, limited-risk, and minimal-risk deployments. Consumer brands often fall into limited-risk or minimal-risk categories, while AI used in hiring, lending, education, insurance, healthcare, or regulated decision-making can move quickly into high-risk obligations such as conformity assessments, technical documentation, human oversight, post-market monitoring, accuracy requirements, and transparency duties.

Companies are advised to stress-test aggressive enforcement, selective scrutiny of large U.S. brands, possible U.S. regulatory expansion, and retrenchment of AI features in Europe. A stronger posture includes public AI inventory disclosures, named governance leadership, board-level oversight, investor communications about AI exposure, trade press positioning, and pre-drafted crisis responses. Maximum penalties are described as up to 7% of global annual turnover.